Bidard, F. C., Bachelot, T., Savignoni, A., Babau, J. M., Werutsky, G., Manna, M., Reinisch, M., Mastro, L. D., Kroep, J. R., Calvo, E. G., Roux, E., Parulekar, W. R., Loibl, S., Rodrigues, L., Leeuwen-Stok, A. E. V., Rothgiesser, K. M., Oliveira, M., Mijonnet, S., Marques, S., Sandoval, J. (2026). NoLEEta: No chemotherapy in intermediate-risk HR+ HER2− early breast cancer treated with ribociclib in the adjuvant setting—A non-inferiority phase III trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps645